Proton therapy, an advanced form of cancer treatment, has gained momentum worldwide due to its precision and minimal side effects on healthy tissues. Changing the approach to cancer treatment in India, proton therapy has been progressing in the field of oncology. Its accuracy and the reduced harm it causes to surrounding tissues make it a viable option for patients. Let's examine the present status, potential, and effect of proton therapy on cancer treatment in India and worldwide.
According to Dr Nikhil Mathur, Chief of Medical Services at CARE Hospitals Group, proton therapy adoption in India is in its early stages. The country's first proton therapy center was established in Chennai in 2019, with only two other centers currently operational. However, the demand for proton therapy is rising exponentially, driven by its unique benefits, including the ability to deliver precise doses of radiation to tumors while sparing surrounding healthy tissue.
Key trends
In 2020, the worldwide proton therapy market was valued at approximately $1.1 to $1.3 billion. Despite variations in growth rates, the global market has been experiencing a steady annual growth rate of four percent to five percent. In contrast, India's market has experienced slower growth due to adoption challenges and infrastructure development issues. Additionally, limited insurance coverage for proton therapy treatments in India has contributed to the slower growth rate.
Diese Geschichte stammt aus der November 2023-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der November 2023-Ausgabe von Healthcare Radius.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Dengue-related searches surge on Justdial
Justdial data reveals significant increase in dengue-related searches and pest control services this monsoon season, amid severe dengue outbreak in India.
Ipca launches NovaLead's Diulcus for diabetic foot ulcer
Ipca Laboratories launches NovaLead's patented drug Diulcus, for the treatment of diabetic foot ulcer in India.
Sahyadri Hospitals unveils advanced radiotherapy treatment
Sahyadri Hospitals launches Asia's first advanced radiotherapy treatment, Radixact X9 system with Vital Hold technology for precise cancer treatment.
Complex liver transplant saves diabetic patient
Wockhardt Hospitals, Mumbai Central and South Asian Liver Institute provide liver transplant services to a Botswanian patient.
Gynecological cancers rise in young Indian women
Experts stress need for awareness, early screening, and advanced treatment options like robotic-assisted surgery for gynecological cancers.
Mahajan Imaging, Siemens unveil AI diagnostic analyzer
Mahajan Imaging and Labs and Siemens Healthineers launch India's first Al-diagnostic analyzer.
Nimotuzumab boosts head and neck cancer survival - Tata Memorial study
A Tata Memorial study finds Nimotuzumab increases 10-year survival rate for head and neck cancer patients.
Kolkata doctor rape and murder: Everything you wanted to know
Protesting doctors demand better workplace safety and stricter policy measures.
AYUSH treatments to be covered under PM-JAY?
Very soon, AYUSH treatments may be covered under AB PM-JAY.
WHAT DOCTORS MUST TELL PATIENTS ABOUT DRY EYE SYNDROME
Dry eye syndrome affects lakhs of people globally, causing discomfort and vision issues. Learn how doctors must guide patients about managing it.